- Record: found
- Abstract: not found
- Article: not found
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs From the perspective of a large group of CML experts
C Abboud, E. BERMAN, A. COHEN, J. CORTÉS, D. DeAngelo, M Deininger, E Berman, A Cohen, A. Neufeld-Cohen, J Cortes, S. Devine, B Druker, A Fathi-Ashtiani, E Jabbour
2013
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.